Evidence map›Paper›PMID 19380252›Full record

ArticleTrends in molecular medicine2009

The PI3K-PTEN tug-of-war, oxidative stress and retinal degeneration.

Kyung Hwa Kang, Greg Lemke, Jin Woo Kim

Abstract read
In one paragraph

Article in Trends in molecular medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Review
  3. Extracts ofMolecules (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Functional 3-Dimensional Retinal Organoids:Frontiers in neuroscience · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Genetic architecture of natural variation in visual senescence in Drosophila.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kyung Hwa KangDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, 335 Gwahangno, Yuseong-gu, Daejeon 305-701, South Korea.
Greg Lemke
Jin Woo Kim

Funding

Eye Development: Genetic StudiesR01EY017478 · NEI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI LEMKE, GREG E · 2006 to 2013
$4.0M
NEI NIH HHS R01 EY017478
6 · The paper itself

Abstract

The retinal pigment epithelium (RPE) is indispensable for photoreceptor function, not only because it provides functional photopigments to photoreceptors, but also because it eliminates oxidatively damaged materials from photoreceptors. Maintaining homeostatic antioxidative programs that support a healthy RPE is therefore important for the normal functioning of the eye. These homeostatic mechanisms, however, often fail in aged RPE cells that have been exposed repeatedly to excessive oxidative stress. When RPE cells succumb to oxidative stress, their death contributes to the development of retinal degenerative diseases such as age-related macular degeneration. Recent studies have highlighted the importance of reciprocal phosphoinositide signaling events orchestrated by phosphoinositide 3-kinase (PI3K) and phosphatase and tensin homolog (PTEN) in the homeostatic programs that protect RPE cells against oxidative stress. Here, we discuss the role of PI3K signaling pathways in RPE cells and suggest that they might be crucial targets of oxidative molecules that initiate early pathological events in retinal degenerative diseases.

Indexed as

Oxidative StressAnimalsAntioxidantsCell PolarityCell SurvivalHumansPhosphatidylinositol 3-KinasesPhotoreceptor CellsPTEN PhosphohydrolaseRetinal DegenerationRetinal Pigment EpitheliumSignal TransductionAntioxidantsPhosphatidylinositol 3-KinasesPTEN Phosphohydrolase

Identifiers

PMID19380252
PMCPMC2993245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.